tiprankstipranks
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market
BCAX
Bicara Therapeutics Inc.
RESEARCH TOOLSreports
Want to see BCAX full AI Analyst Report?

Bicara Therapeutics Inc. (BCAX) Stock News & Sentiment

79 Followers
Bicara Highlights Durable Three-Year Data for Ficerafusp Alfa
Premium
Company Announcements
Bicara Highlights Durable Three-Year Data for Ficerafusp Alfa
2d ago
8K
BCAX
Bicara Therapeutics Highlights Momentum in Earnings Call
Premium
Company Announcements
Bicara Therapeutics Highlights Momentum in Earnings Call
4d ago
BCAX
Bicara Therapeutics’ Earnings Call Highlights Ficera Momentum
Premium
Company Announcements
Bicara Therapeutics’ Earnings Call Highlights Ficera Momentum
5d ago
BCAX
BCAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BCAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
BCAX
Bicara Therapeutics’ Acquisition Strategy Poses Operational, Financing, and Shareholder Dilution Risks
Premium
Company Announcements
Bicara Therapeutics’ Acquisition Strategy Poses Operational, Financing, and Shareholder Dilution Risks
11d ago
BCAX
Tyler Van Buren Reiterates Buy Rating on Ficera, Citing Strong Phase III Momentum and Best-in-Class Potential in HPV-Negative Head and Neck Cancer
Premium
Ratings
Tyler Van Buren Reiterates Buy Rating on Ficera, Citing Strong Phase III Momentum and Best-in-Class Potential in HPV-Negative Head and Neck Cancer
13d ago
BCAX
Bicara Therapeutics’ Earnings Call Highlights Pivotal Pivot
Premium
Company Announcements
Bicara Therapeutics’ Earnings Call Highlights Pivotal Pivot
2M ago
BCAX
More BCAX News >

BCAX News on the Web

BCAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Bullish
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet | The Motley Fool
Motley Fool
Bullish
Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data
MarketBeat
Bullish
Wedbush Keeps Their Buy Rating on Bicara Therapeutics Inc. (BCAX)
TipRanks News
Bullish
Bicara Therapeutics’ Acquisition Strategy Poses Operational, Financing, and Shareholder Dilution Risks
TipRanks News
Bearish
BCAX SWOT Analysis: Key Risks and Opportunities Revealed in 10-Q Filing
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Verrica Pharmaceuticals (VRCA) and Kura Oncology (KURA)
TipRanks News
Bullish
Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
BCAX
Sector Average
Media Buzz
This Week7 articles
Weekly Average5.25 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BCAX’s Media Buzz Sentiment?
7 articles about BCAX were published this week. In an average week, 5.25 articles are published.
    What is BCAX’s weekly average amount of articles?
    In an average week, 5.25 articles about BCAX are published.
      What is BCAX’s News Sentiment?
      99% of articles about BCAX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week